James Anderson
James is responsible for leading the delivery of IFPMA’s relevant policy and advocacy work. In his previous role as Head of Corporate Government Affairs at GSK, James led engagement with the UK Government spanning GSK’s pharmaceuticals, vaccines, and consumer businesses. James also led GSK’s strategy and advocacy on Antimicrobial Resistance (AMR). He advised on AMR policy development at the WHO, UN, EU Commission, the O’Neill Review and National Governments. He is in the Founding team of the AMR Action Fund and led the development of the Davos Declaration and 2016 UNGA Industry AMR Roadmap.
